Cargando…

Glatiramer acetate treatment negatively regulates type I interferon signaling

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660947/
https://www.ncbi.nlm.nih.gov/pubmed/26665148
http://dx.doi.org/10.1212/NXI.0000000000000189
_version_ 1782402905585745920
collection PubMed
description
format Online
Article
Text
id pubmed-4660947
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-46609472015-12-10 Glatiramer acetate treatment negatively regulates type I interferon signaling Neurol Neuroimmunol Neuroinflamm Correction Lippincott Williams & Wilkins 2015-11-24 /pmc/articles/PMC4660947/ /pubmed/26665148 http://dx.doi.org/10.1212/NXI.0000000000000189 Text en © 2015 American Academy of Neurology
spellingShingle Correction
Glatiramer acetate treatment negatively regulates type I interferon signaling
title Glatiramer acetate treatment negatively regulates type I interferon signaling
title_full Glatiramer acetate treatment negatively regulates type I interferon signaling
title_fullStr Glatiramer acetate treatment negatively regulates type I interferon signaling
title_full_unstemmed Glatiramer acetate treatment negatively regulates type I interferon signaling
title_short Glatiramer acetate treatment negatively regulates type I interferon signaling
title_sort glatiramer acetate treatment negatively regulates type i interferon signaling
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660947/
https://www.ncbi.nlm.nih.gov/pubmed/26665148
http://dx.doi.org/10.1212/NXI.0000000000000189